Vaxart 10K 2015 Annual report | VXRT Filing

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: ablation, affirming, afflicted, aggressive, Aldara, Anaconda, anal, andin, ANMAT, anogenital, answer, AORRP, area, Argentina, Ark, Asthmaand, asymptomatic, Bavarian, benign, Biotech, bivalent, BN, breach, breathing, bronchodilator, burning, categorized, celluloscreening, cellulowith, center, Cervarix, cervical, check, Chile, Chilean, choice, chronicobstructive, cidofovir, Circuit, clearance, cm, commercializeLANI, condyloma, condylomaand, Condylox, copying, cryotherapy, CSL, currentlydo, decreaseddue, decreasedprimarily, delinquent, deplete, diagnosed, diagram, doesnot, dye, electrical, eleven, endoscopic, enterprise, epithelia, equitableagreement, erythema, escrow, eSensor, excellent, exploited, expressly, facie, fatal, feasibility, filer, forLANI, France, French, fromthenet, Gardasil, gel, genital, genitourinary, GenMark, hasimpaired, HPV, hyperproliferation, IfArgentine, imiquimod, inappropriate, innate, innovativeor, InteractionTrial, intralesional, IP, irrespective, itching, Johnson, JORRP, larynx, laser, lengthen, lethal, loan, lossdue, MAD, malignant, margin, mark, MEDI, MedImmune, Merck, monoclonal, morphology, mucosa, mucosal, multicenter, Nordic, Novavax, ofAnaconda, ofLANI, ofRSV, ofsufficient, ofthe, ongoingclinical, onsignificant, oropharyngeal, ouranticipatedtiming, ourclinical, ourRSVpreclinical, pasta, patentapplicationin, pathology, PCR, pile, plasma, podophyllotoxin, post, posted, preforming, prima, pronouncement, prophylactic, psychosocial, PTAB, pulse, quadrivalent, Rapivab, recurrent, Regeneron, rehearing, reliever, reoccurrence, replicationin, reporteda, republication, rewarded, RRP, SAD, screened, screening, sexually, shell, sixteen, skin, slightly, StageAntiviralProduct, STD, stranded, Subtopic, supplier, surgery, surgical, surgically, swallowing, telecommunication, terrorism, Teva, theclosure, theinitiation, theLANI, thereunder, toconduct, todevelop, toevaluate, toLANIoutside, top, toreacha, tosupportour, trail, transmitted, trichloroacetic, undergo, unique, unrecorded, USPATB, USPTAB, vaginal, vapendavirPhase, vehicle, Veregen, Virazole, visit, vulvar, war, wart, Wartec, Wedo, Zyclara

Removed: appointed, approach, biochemistry, biological, biology, CMC, combined, consisting, Dr, Ernst, finally, Hill, immunization, leading, molecular, notwithstanding, open, partially, President, quickly, recognition, reducing, release, remained, role, shareholder, statistical, today, toxic, transition

Vaxart (VXRT) 10-K2015 FY Annual report

Content analysis